Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @group_jackson
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @group_jackson
-
Jackson Consulting Group proslijedio/la je Tweet
Gene sequences have led to diagnostic tests for the virus, but they're no substitute for virus samples, which are needed to test drugs and vaccines.https://go.nature.com/2Op3mN1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
While researchers are racing to unravel the molecular mechanisms behind tumour-promoting bacteria, many cancer researchers are testing whether microbiome-based therapeutics can improve the efficacy or safety of existing anti-cancer interventions.https://go.nature.com/2vEzndz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
The 2019
#GFINDER Report indicates that global investment in TB R&D continues to fall short.@StopTB says an estimated 2.16B is still needed annually to deliver new tools to treat, diagnose and prevent#tuberculosis. https://bit.ly/2U3l78h#EndTBpic.twitter.com/WetApoOAL5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
Researchers at
@UCLAJCCC suggest that using an immunotherapy drug called NKTR-214 in combination with an infusion of anti-tumor immune cells may produce a stronger immune response that could help fight advanced melanoma. https://bit.ly/2Upby3F#melnmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
“Back to home, back to family, back to work, back to life and back to self.” That’s the motto of our Enhanced Recovery Program for surgery. Our
@mdahpbaloia explains: http://bit.ly/3ad9st9#endcancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
Resource: quantitative proteomics of 375 cell lines in the Cancer Cell Line Encyclopedia http://bit.ly/2tMtaeX
#NBThighightHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
“The time from diagnosis to cancer treatment is significantly shorter,” says our Dr. Katy Rezvani of the advantages of CAR NK cell therapy: http://bit.ly/2MhA4Pl
#CancerMoonshot#endcancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
#AntimicrobialResistance could push 28M people into extreme poverty every year by 2050. Ahead of the Prince Mahidol Award Conference next week in Thailand, see why universal health coverage matters for achieving#GlobalGoals: http://expi.co/01nb2Z#PMAC2020#HealthForAllpic.twitter.com/VKbWuNFTr9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
CAR-T cells for solid tumors: there's a new target, Claudin-6. And combination with an RNA vaccine delivering Claudin-6 to immune cells boosts their function in mouse models of cancer http://bit.ly/2U2GM0b
#NBThighlightHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
Great podcast! Dr. Shannon goes from the basics to the nuance about
#cancerresearch#leukemia#immunotherapy and ends with gratitude to patients, caregivers, and families who partner with researchers to move the needle forward on#ChildhoodCancerhttps://twitter.com/ACS_Research/status/1220789015332388865 …
0:45Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
New tools are urgently needed to
#EndTB. Congratulations to the@GatesMRI on receiving a license from@GSK to advance a promising#tuberculosis vaccine candidate!
https://www.bloomberg.com/news/articles/2020-01-27/gates-research-institute-to-develop-glaxo-s-promising-tb-vaccine …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
Three Biosimilars Entering US Oncology Market at Substantial Discounts: Three biosimilars—bevacizumabbvzr Zirabev rituximabpvvr Ruxience and trastuzumabqyyp—will become available in the United States at a substantial discount to their…http://bioportfol.io/RNdF15
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
Tuberculosis Cohort in the North of Paris: Tuberculosis TB is the leading cause of death from infectious disease in the world just behind HIV AIDS. Since 2005 the department of Seine Saint Denis the poorest of France with difficult socioeconomic…http://bioportfol.io/RNc8kk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
#StigmaAndTB Mansi shares her experience with stigma and#TB.#EndTB#EndTheStigma#TalkingTB@ddgtb2017@TBHDJ@Debshree_DDL@findingsau@patelhimanshuk2@sundaekrish@BiBeKDeep@keyuriab@MoHFW_INDIA@YouthKiAwaazpic.twitter.com/1AMqFNUDst
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
Previous NAS Public Welfare Medal recipient, Alan Alda, is teaming up with Scripps Research - one of the largest science and medical research communities in the country - to teach scientists and medical professionals to communicate more effectively.http://ow.ly/bwkq50y39Kj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
A team of Australian scientists, including CRI Scientific Advisory Council member
@jonceb of@ONJCRI, have discovered how gamma-delta T cells become activated. This breakthrough could lead to the development of new and improved immunotherapy treatments.https://bit.ly/2sS9rtZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
First Laura was misdiagnosed, then her story was sensationalized on local TV as a schoolteacher whose TB infection threatened her students. But her community rallied around her, and Laura now openly shares her story of resilience and
#TBCourage. https://bit.ly/2FDl2jg pic.twitter.com/VO3BjrIbdv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
SQZ AACs have the potential to address multiple
#oncology indications. Learn more about AACs and their unique mechanism of action here: http://bit.ly/2ur9eyl pic.twitter.com/x7J34OlivV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
CRI Lloyd J. Old STAR
@MarsonLab of@UCSF and team have published a new paper in@NatureBiotech on improved#genome targeting across diverse human blood cell types with polymer-stabilized Cas9 nanoparticles and modified HDR templates.https://www.nature.com/articles/s41587-019-0325-6 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jackson Consulting Group proslijedio/la je Tweet
“For any reason you can think of to turn off CRISPR systems, anti-CRISPRs come into play,” says Dr. Kevin Forsberg of Fred Hutchhttps://go.nature.com/2G0cKSw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.